Rheumatoid Arthritis: Diagnosis and Management for the Family Physician

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Rheumatoid arthritis (RA) is a prevalent chronic autoimmune disease affecting 0.5%–1% of North Americans.
• RA leads to joint inflammation, erosion, deformity, significant morbidity, disability, and increased mortality.
• Early suspicion is key, especially with polyarthritis, morning stiffness, and constitutional symptoms.

Purpose of the Study:

• To provide an overview of rheumatoid arthritis diagnosis and management.
• To highlight the importance of early detection and treatment strategies.
• To discuss current therapeutic approaches and patient management considerations.

Main Methods:

• Review of diagnostic criteria and clinical presentation of RA.
• Discussion of laboratory tests including inflammatory markers, rheumatoid factor, and anti-CCP antibodies.
• Examination of treatment guidelines, including methotrexate, treat-to-target approaches, and advanced therapies like biologics and targeted synthetic DMARDs.

Main Results:

• RA diagnosis is supported by clinical features and specific serological markers.
• Effective management involves a treat-to-target strategy aiming for remission.
• Biologic and targeted synthetic DMARDs have significantly improved patient quality of life.

Conclusions:

• RA, while incurable, is manageable with modern therapies.
• Prompt diagnosis and treatment are crucial for optimal outcomes.
• Patients require monitoring for infections and cardiovascular risk factors due to DMARD use.